Edwards Lifesciences Corporation (EW) Earns "Positive" Rating from Northland Securities

Edwards Lifesciences Corporation (EW) Earns "Positive" Rating from Northland Securities


's stock had its "positive" rating restated by equities researchers at Northland Securities in a report released on Tuesday. They presently have a $105.00 price target on the medical research company's stock.



from Biotech News